| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |